Therapy News and Research

RSS

Prana Biotechnology raises U.S.$6 Million to fund trial of PBT2 in patients with Alzheimer's disease.

Prana Biotechnology today announced it has entered into agreements to raise approximately A$7.77 million (US$6 million) from new institutional investors in Australia, existing institutional investors in the United States and a founding member of the Company.

20 Nov 2006

Africa's health problems are getting worse says the WHO

The World Health Organisation (WHO) says regardless of promises of better healthcare by governments and donor countries, millions of mothers, newborn babies and children continue to die each year in Africa from preventable diseases.

20 Nov 2006

Quality of life for dementia patients improved by occupational therapy

According to researchers in the Netherlands, occupational therapy improves the quality of life for dementia patients and their carers.

20 Nov 2006

Indian state to tackle workplace HIV discrimination

India's wealthiest state, Maharashtra is about to become the first state to introduce a policy which aims to attack the discrimination suffered by those infected with HIV in the workplace.

20 Nov 2006

Nanotechnology continues to advance anticancer gene therapy

Given that cancer is a disease in which genetic errors play a major role, it should come as no surprise that many experts envision a time when gene therapy will play an equally important role in the treatment of cancer.

20 Nov 2006

Low-field magnetic separation of monodisperse Fe3O4 nanocrystals

Whether the goal is to separate different types of cells or molecules, methods that rely on the age-old principle of magnetism are a staple among researchers.

20 Nov 2006

Africa is developing solutions for fighting disease and improving health

The signs are everywhere, across the continent: Africa is finding African approaches to solving its health problems.

20 Nov 2006

Cancer Research Technology and University of Manchester announce collaboration in oncology with AstraZeneca

Cancer Research Technology Limited (CRT), the oncology-focused development and commercialisation company, and The University of Manchester have entered into an agreement with AstraZeneca to establish a clinical pharmacology biomarker research and discovery collaboration.

20 Nov 2006

HRT shows promise in helping visual memory of postmenopausal women

Many women experience declines in their memory during and after menopause, a change thought to be due, in part, to the rapid hormonal changes they weather during that time.

20 Nov 2006

Risk to childhood cancer survivors for late-occurring strokes

Children who are successfully treated for brain tumors or leukemia are more likely to have strokes later in life, according to new research from UT Southwestern Medical Center.

20 Nov 2006

Experimental drug provides powerful therapy against acute myeloid leukemia

Researchers at The University of Texas M. D. Anderson Cancer Center have found, in laboratory studies, that the experimental drug ABT-737 which has shown promise in some cancers, can destroy acute myeloid leukemia (AML) blast, progenitor and even stem cells that are often resistant to standard chemotherapy treatment.

19 Nov 2006

Evolution is driving therapeutic resistance to cancer therapies

The dynamics of evolution are fully in play within the environment of a tumor, just as they are in forests and meadows, oceans and streams.

19 Nov 2006

FDA expands use of Herceptin

The U.S. Food and Drug Administration (FDA) has expanded the approved use of Herceptin, a biological cancer drug. The new indication is for Herceptin, in combination with other cancer drugs, for the treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy).

19 Nov 2006

Community occupational therapy for patients with dementia and their caregivers

Occupational therapy can help to improve the ability of people with dementia patients to perform daily activities and can also reduce the pressure on their caregivers, says a British Medical Journal study.

19 Nov 2006

Angioplasty no better than drugs for heart attack victims who delay treatment

In what will come as a surprise to many doctors, researchers in the United States how found that contrary to current belief, heart attack survivors with mild or no symptoms who wait three days or more to seek medical help, will achieve little benefit from the procedures used to open clogged arteries.

15 Nov 2006

Stem cell therapy promises hope for muscular dystrophy victims

Italian scientists, by using new stem cell therapy on dogs with muscular dystrophy, have improved the dogs condition to such an extent that the dogs were able to walk and even jump again.

15 Nov 2006

Investigational drug tolvaptan treats hyponatremia

Results of the two largest studies on hyponatremia, SALT-1 and SALT-2, presented Nov. 14 at the American Heart Association's Scientific Sessions in Chicago, found that the investigational drug tolvaptan treated hyponatremia -- water intoxication -- faster and more effectively than available treatments.

14 Nov 2006

Testosterone replacement therapy appears to be safe - has little effect on the prostate gland

Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that this therapy may be harmful, according to a study in the November 15 issue of JAMA: The Journal of the American Medical Association.

14 Nov 2006

Food can have an impact in preventing cancer

With cancer, researchers don't believe "you are what you eat"; that disease is always a direct result of what is, or what isn't, on your dinner plate.

14 Nov 2006

New gold standard of care for overactive bladder

A major clinical trial finds that a combination of two common medications -- tolterodine (Detrol LA) and tamsulosin (Flomax) -- works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).

14 Nov 2006